Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
May 7, 2018
Document Date
May 7, 2018
Form Description
Correspondence Related to Draft Registration Statement
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/